Biotech, Food & Drug

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotechnology, Food & Drug Administration FDA News

Title
Publication Date Organization
Aug
29
2017
National Milk Producers Federation Working to Improve Labor Challenges Varnum LLP
Aug
29
2017
CAFC Vacates USPTO Single Reference Obviousness Rejection For Inadequate Showing Of Expectation of Success Foley & Lardner LLP
Aug
28
2017
NYC OATH Decision Finds for Medical Marijuana User Epstein Becker & Green, P.C.
Aug
28
2017
FDA Commissioner Issues Statement Touting Menu Labeling Rule, Announces Additional Guidance is Forthcoming Keller and Heckman LLP
Aug
28
2017
How Distinctive Can a Chocolate Bar be? After Kit Kat, Now It’s Toblerone’s Turn K&L Gates
Aug
25
2017
The Ohio BWC’s New Rule on Low Back Fusion Surgery Dinsmore & Shohl LLP
Aug
25
2017
Jury Tests the Limits in AndroGel False Ad Verdict Proskauer Rose LLP
Aug
25
2017
Bill To Repeal Bioenergy Subsidies Introduced In The House Of Representatives Bergeson & Campbell, P.C.
Aug
25
2017
Pharmaceutical Companies Agree to Pay $465 Million Settlement in EpiPen False Claims Act Lawsuit Tycko & Zavareei LLP
Aug
25
2017
FDA Releases Compliance Guide for Small Businesses under FSMA Intentional Adulteration Rule Keller and Heckman LLP
Aug
25
2017
PTO Litigation Report – August 25, 2017 Sterne, Kessler, Goldstein & Fox P.L.L.C.
Aug
25
2017
EPA Will Hold September Webinar on PBT Chemicals under TSCA Bergeson & Campbell, P.C.
Aug
24
2017
NIOSH Draft Research Agenda for Manufacturing Addresses Nanomaterials Bergeson & Campbell, P.C.
Aug
24
2017
FTC Settles with Breeder Trade Association over Association Rules That Limited Price Competition for Dairy Bull Semen McDermott Will & Emery
Aug
24
2017
EPA OIG Will Evaluate Chemical Data Reporting under TSCA Bergeson & Campbell, P.C.
Aug
24
2017
USDA Rolls Out New Animal Welfare Compliance Database Keller and Heckman LLP
Aug
24
2017
2017 EU-U.S. Workshop Will Be Held September 7-8, 2017 Bergeson & Campbell, P.C.
Aug
23
2017
FDA Issues Guidance on Qualification of Medical Device Development Tools Alert Barnes & Thornburg LLP
Aug
23
2017
FDA Enters the Menu Labeling Food Fight Morgan, Lewis & Bockius LLP
Aug
23
2017
Understanding Bolar and Bolar-Like Exceptions in the U.S. and Abroad – Part 2 – Canada Michael Best & Friedrich LLP
Aug
23
2017
FDA Launches Food Safety Plan Builder to Facilitate FSMA Compliance Keller and Heckman LLP
Aug
23
2017
SAP Meeting on Continuing Development of Alternative High-Throughput Screens to Determine Endocrine Disruption Bergeson & Campbell, P.C.
Aug
22
2017
NGOs Call for France to Require Labeling and Restriction of Consumer Products Bergeson & Campbell, P.C.
Aug
22
2017
USDA-FSIS Issues Updated Guidelines for Premarket Label Approval Keller and Heckman LLP
Aug
21
2017
Food Identity Disputes Continue to Impose High-Profile Pressure on FDA Mintz
Aug
21
2017
OIE Publishes Report on Global Antimicrobial Use Keller and Heckman LLP
Aug
21
2017
Athena Diagnostics, Inc. v. Mayo (D. Mass., August 4, 2017) – “That’s all,” She Wrote. Schwegman, Lundberg & Woessner, P.A.
Aug
21
2017
EpiPen Maker Mylan Gets Stuck With $465 Million Fine; Politicians Say it Doesn’t Sting Enough Cadwalader, Wickersham & Taft LLP
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins